CLINICAL_TRIALS
trial_result
· 2013-11-21
Clinical Trial Update: A Study of BIBW 2992 (Afatinib) in Patients With Metastatic Colorectal Cancer [Phase 2]
Summary
A Phase 2 study of afatinib (BIBW 2992) in metastatic colorectal cancer has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Colorectal Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2013-11-21